NICE (National Institute for Clinical Excellence) reviews technology appraisal guidance for companies
This article was originally published in Clinica
The UK's National Institute for Clinical Excellence (NICE) is reviewing its technology appraisal submissions guidance for manufacturers and sponsors, ahead of new guidance due to be implemented in October.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.